Multiple rpoB mutants of Mycobacterium tuberculosis and second-order selection.
作者信息
Mokrousov Igor
出版信息
Emerg Infect Dis. 2004 Jul;10(7):1337-8. doi: 10.3201/eid1007.030598.
Abstract
摘要
相似文献
1
Multiple rpoB mutants of Mycobacterium tuberculosis and second-order selection.
Emerg Infect Dis. 2004 Jul;10(7):1337-8. doi: 10.3201/eid1007.030598.
2
[Molecular mutations of rpoB gene of multidrug resistant Mycobacterium tuberculosis isolates from China].
Yi Chuan Xue Bao. 2004 Dec;31(12):1332-6.
3
[Characterization of rpoB mutation in rifampin - resistant clinical Mycobacterium tuberculosis isolates from China].
Zhonghua Jie He He Hu Xi Za Zhi. 2001 Apr;24(4):231-5.
4
Cross-resistance between rifampicin and KRM-1648 is associated with specific rpoB alleles in Mycobacterium tuberculosis.
Int J Tuberc Lung Dis. 2002 Feb;6(2):166-70.
5
[Resistance to rifampin of mycobacterium tuberculosis and rpoB gene].
Zhonghua Jie He He Hu Xi Za Zhi. 2000 Nov;23(11):692-4.
6
[Detecting rpoB gene mutation in rifampin-resistant Mycobacterium tuberculosis by using the reverse dot-blot hybridization method].
Zhonghua Jie He He Hu Xi Za Zhi. 2002 Oct;25(10):591-4.
7
Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis.
Clin Microbiol Infect. 2004 Apr;10(4):289-94. doi: 10.1111/j.1198-743X.2004.00889.x.
8
In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
Clin Microbiol Infect. 2004 Jul;10(7):662-5. doi: 10.1111/j.1469-0691.2004.00917.x.
9
Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.
Chin Med J (Engl). 1999 Jun;112(6):524-8.
10
Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.
J Clin Microbiol. 2001 Jan;39(1):107-10. doi: 10.1128/JCM.39.1.107-110.2001.
引用本文的文献
1
Distribution and frequency of common mutations in gene of detected by Xpert MTB/RIF and identification of residential areas of rifampicin resistant-TB cases: A first retrospective study from Mizoram, Northeast India.
J Clin Tuberc Other Mycobact Dis. 2022 Nov 24;29:100342. doi: 10.1016/j.jctube.2022.100342. eCollection 2022 Dec.
2
Compensatory effects of mutations outside the rifampicin resistance-determining region.
Emerg Microbes Infect. 2021 Dec;10(1):743-752. doi: 10.1080/22221751.2021.1908096.
3
Characterization of mutations in the rpoB gene conferring rifampicin resistance in Mycobacterium tuberculosis complex isolated from lymph nodes of slaughtered cattle from South Africa.
Braz J Microbiol. 2020 Dec;51(4):1919-1927. doi: 10.1007/s42770-020-00356-4. Epub 2020 Aug 5.
4
Transcriptional Approach for Decoding the Mechanism of Compensatory Mutations for the Fitness Cost in Rifampicin-Resistant .
Front Microbiol. 2018 Nov 30;9:2895. doi: 10.3389/fmicb.2018.02895. eCollection 2018.
5
The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?
Emerg Microbes Infect. 2014 Mar;3(3):e17. doi: 10.1038/emi.2014.17. Epub 2014 Mar 12.
6
Mycobacterium tuberculosis population in northwestern Russia: an update from Russian-EU/Latvian border region.
PLoS One. 2012;7(7):e41318. doi: 10.1371/journal.pone.0041318. Epub 2012 Jul 23.
7
Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.
J Clin Microbiol. 2011 Jul;49(7):2502-8. doi: 10.1128/JCM.00197-11. Epub 2011 May 11.
8
High-level rifampin resistance correlates with multiple mutations in the rpoB gene of pulmonary tuberculosis isolates from the Afghanistan border of Iran.
J Clin Microbiol. 2009 Sep;47(9):2744-50. doi: 10.1128/JCM.r00548-09.
9
Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia.
Antimicrob Agents Chemother. 2008 Aug;52(8):2937-9. doi: 10.1128/AAC.00036-08. Epub 2008 Jun 16.
10
Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency.
Ann Clin Microbiol Antimicrob. 2005 Jun 15;4:9. doi: 10.1186/1476-0711-4-9.
本文引用的文献
1
Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family.
Emerg Infect Dis. 2003 Jul;9(7):838-45. doi: 10.3201/eid0907.020803.
2
Importance of uracil DNA glycosylase in Pseudomonas aeruginosa and Mycobacterium smegmatis, G+C-rich bacteria, in mutation prevention, tolerance to acidified nitrite, and endurance in mouse macrophages.
J Biol Chem. 2003 Jul 4;278(27):24350-8. doi: 10.1074/jbc.M302121200. Epub 2003 Apr 5.
3
Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India.
J Clin Microbiol. 2001 Aug;39(8):2987-90. doi: 10.1128/JCM.39.8.2987-2990.2001.
4
Compensatory evolution in rifampin-resistant Escherichia coli.
Genetics. 2000 Dec;156(4):1471-81. doi: 10.1093/genetics/156.4.1471.
5
Escherichia coli DNA polymerase IV mutator activity: genetic requirements and mutational specificity.
J Bacteriol. 2000 Aug;182(16):4587-95. doi: 10.1128/JB.182.16.4587-4595.2000.
6
Genetic antagonism and hypermutability in Mycobacterium smegmatis.
J Bacteriol. 2000 Jun;182(12):3331-5. doi: 10.1128/JB.182.12.3331-3335.2000.
7
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.
Science. 2000 May 19;288(5469):1251-4. doi: 10.1126/science.288.5469.1251.
8
Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 1999 Aug;43(8):1866-9. doi: 10.1128/AAC.43.8.1866.
9
rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy.
J Clin Microbiol. 1999 Apr;37(4):1197-9. doi: 10.1128/JCM.37.4.1197-1199.1999.
10
Comparative mycobacterial genomics.
Curr Opin Microbiol. 1998 Oct;1(5):567-71. doi: 10.1016/s1369-5274(98)80090-8.
Zotero 插件